Cargando…
Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
ω3‐polyunsaturated free fatty acids (ω3‐PUFAs), particularly docosahexaenoic (DHA) and eicosapentaenoic acid (EPA), are thought to exert health promoting effects in metabolic and in inflammatory diseases. The molecular mechanisms of these beneficial effects are only partially understood. DHA and EPA...
Autores principales: | Wannick, Melanie, Bezdek, Siegfried, Guillen, Nathalie, Thieme, Markus, Meshrkey, Fibi, Mousavi, Sadegh, Seeling, Michaela, Nimmerjahn, Falk, Mócsai, Attila, Zillikens, Detlef, Sezin, Tanya, Sadik, Christian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223243/ https://www.ncbi.nlm.nih.gov/pubmed/30455959 http://dx.doi.org/10.1002/prp2.438 |
Ejemplares similares
-
The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation
por: Jegodzinski, Lina, et al.
Publicado: (2020) -
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
por: Milligan, Graeme, et al.
Publicado: (2017) -
The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)
por: Hudson, Brian D., et al.
Publicado: (2014) -
Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science
por: Son, So-Eun, et al.
Publicado: (2021) -
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis
por: Bezdek, Siegfried, et al.
Publicado: (2018)